TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity

被引：387
作者：
Baccala, Roberto [1 ]
Hoebe, Kasper [1 ]
Kono, Dwight H. [1 ]
Beutler, Bruce [1 ]
Theofilopoulos, Argyrios N. [1 ]
机构：
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 93037 USA
来源：
NATURE MEDICINE | 2007年 / 13卷 / 05期
关键词：
D O I：
10.1038/nm1590
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
We formulate a two-phase paradigm of autoimmunity associated with systemic lupus erythematosus, the archetypal autoimmune disease. The initial Toll-like receptor (TLR)-independent phase is mediated by dendritic cell uptake of apoptotic cell debris and associated nucleic acids, whereas the subsequent TLR-dependent phase serves an amplification function and is mediated by uptake of TLR ligands derived from self-antigens (principally nucleic acids) complexed with autoantibodies. Both phases depend on elaboration of type I interferons (IFNs), and therapeutic interruption of induction or activity of these cytokines in predisposed individuals might have a substantial mitigating effect in lupus and other autoimmune diseases.
引用
收藏
页码：543 / 551
页数：9
相关论文
共 100 条
  • [1] Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs
    Albert, ML
    Sauter, B
    Bhardwaj, N
    [J]. NATURE, 1998, 392 (6671) : 86 - 89
  • [2] Apoptosis in systemic lupus erythematosus - Clinical implications
    Andrade, F
    Casciola-Rosen, L
    Rosen, A
    [J]. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2000, 26 (02) : 215 - +
  • [3] AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154
  • [4] Interferons as pathogenic effectors in autoimmunity
    Baccala, R
    Kono, DH
    Theofilopoulos, AN
    [J]. IMMUNOLOGICAL REVIEWS, 2005, 204 : 9 - 26
  • [5] Lupus glomerulonephritis revisited 2004: Autoimmunity and end-organ damage
    Bagavant, H
    Deshmukh, US
    Gaskin, F
    Fu, SM
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2004, 60 (1-2) : 52 - 63
  • [6] Type I interferon in systemic lupus erythematosus and other autoimmune diseases
    Banchereau, Jacques
    Pascual, Virginia
    [J]. IMMUNITY, 2006, 25 (03) : 383 - 392
  • [7] Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus
    Barrat, FJ
    Meeker, T
    Gregorio, J
    Chan, JH
    Uematsu, S
    Akira, S
    Chang, B
    Duramad, O
    Coffman, RL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (08) : 1131 - 1139
  • [8] Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type IFN
    Bekeredjian-Ding, IB
    Wagner, M
    Hornung, V
    Giese, T
    Schnurr, M
    Endres, S
    Hartmann, G
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (07) : 4043 - 4050
  • [9] Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice
    Berland, Robert
    Fernandez, Luis
    Kari, Elina
    Han, Jin-Hwan
    Lomakin, Ina
    Akira, Shizuo
    Wortis, Henry H.
    Kearney, John F.
    Ucci, Angelo A.
    Imanishi-Kari, Thereza
    [J]. IMMUNITY, 2006, 25 (03) : 429 - 440
  • [10] Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large
    Beutler, Bruce
    Jiang, Zhengfan
    Georgel, Philippe
    Crozat, Karine
    Croker, Ben
    Rutschmann, Sophie
    Du, Xin
    Hoebe, Kasper
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 : 353 - 389
12345678910